Early postoperative infection

In patients with early postoperative arthroplasty device infection, broad-spectrum empirical therapy is required to treat the likely organisms (see Classification and aetiology of arthroplasty device infections). The choice of cefepime, ciprofloxacin or gentamicin (or for patients with immediate severe or delayed severe hypersensitivity to penicillins, the choice of ciprofloxacin or gentamicin) for empirical treatment of Gram-negative organisms should be determined by local epidemiology (if known), local antimicrobial stewardship policy and drug availability.

Modify therapy based on culture and susceptibility results from intraoperative sampling (see Directed antibiotic therapy for arthroplasty device infections). If the results of culture or susceptibility testing are not available by 72 hours or if the culture results are negative, seek expert advice on rationalising therapy.

For empirical therapy in patients with early postoperative arthroplasty device infection, after intraoperative samples have been taken and while awaiting infectious diseases or clinical microbiology advice, use:

vancomycin intravenously; see Intermittent vancomycin dosing in noncritically ill adults for initial dosingvancomycin vancomycin vancomycin

PLUS one of the following

1cefepime 2 g intravenously, 8-hourly. For dosage adjustment in adults with kidney impairment, see cefepime dosage adjustment cefepime cefepime cefepime

OR

1ciprofloxacin 750 mg orally, 12-hourly1. For dosage adjustment in adults with kidney impairment, see ciprofloxacin oral dosage adjustment ciprofloxacin ciprofloxacin ciprofloxacin

OR

1gentamicin intravenously; see Gentamicin initial dose calculator for adults for initial dose. See Principles of aminoglycoside use for prescribing considerations and subsequent dosing. gentamicin gentamicin gentamicin

For patients who have had a nonsevere (immediate or delayed) hypersensitivity reaction to a penicillin, after intraoperative samples have been taken and while awaiting infectious diseases or clinical microbiology advice, use vancomycin plus cefepime, ciprofloxacin or gentamicin (see dosages above).

For empirical therapy in patients who have had a severe (immediate or delayed) hypersensitivity reaction to a penicillin, after intraoperative samples have been taken and while awaiting infectious diseases or clinical microbiology advice, use:

vancomycin intravenously; see Intermittent vancomycin dosing in noncritically ill adults for initial dosing vancomycin vancomycin vancomycin

PLUS EITHER

1ciprofloxacin 750 mg orally, 12-hourly1. For dosage adjustment in adults with kidney impairment, see ciprofloxacin oral dosage adjustment ciprofloxacin ciprofloxacin ciprofloxacin

OR

1gentamicin intravenously; see Gentamicin initial dose calculator for adults for initial dose. See Principles of aminoglycoside use for prescribing considerations and subsequent dosing.gentamicingentamicin gentamicin

1 If the patient cannot tolerate oral therapy, use ciprofloxacin 400 mg intravenously, 8-hourly.Return